The National Institute of Pharmaceutical Education and Research (NIPER-Kolkata) has launched its Open Access Publishing Hub with F1000, Taylor & Francis Group’s open research publishing arm. This will be hosted on the F1000Research site, adopting its pioneering approach to open science publishing.

NIPER-Kolkata will be adopting F1000’s open science practices to increase the reproducibility and accessibility of their published research. This means the research is free for anyone to read and will use the innovative F1000Research publishing model that combines the benefits of rapid publication with mechanisms to assure quality and transparency, thereby accelerating research impact. 

The NIPER-Kolkata gateway provides a home for their conference-linked outputs, enabling their scientific outcomes to be published open access. This gateway welcomes submissions from the fields of, drug discovery, process chemistry, pharmacological studies, natural products, pharmaceutical formulation, computational studies, and medical devices, published in all forms, from traditional research articles to a protocol, registered report, data notes, case studies, and much more.

Dr V Ravichandiran, Director, National Institute of Pharmaceutical Education and Research said, “The National Institute of Pharmaceutical Science (NIPER), Kolkata, is pleased to partner with F1000 to make our open science aspirations a reality. We are excited to openly present our academic endeavours to the scientific community, to enable real-world impact with our research and look forward to seeing our researchers embrace this new way of publishing.”